Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 366

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 366
---
4.

2023
Omnibus Incentive Plan

Our
board of directors has adopted, and our stockholders have approved, the Telomir Pharmaceuticals, Inc. 2023 Omnibus Incentive Plan (the
“2023 Omnibus Plan”) which became effective upon the completion of our initial public offering on February 9, 2024. The 2023
Omnibus Plan will authorize the grant of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code, to
our employees and any of our parent and subsidiary corporations’ employees, and the grant of non-statutory stock options, restricted
stock, restricted stock units, stock appreciation rights, performance units and performance shares to our employees, directors, and consultants
and any of our future subsidiary corporations’ employees and consultants. The following is a summary of certain terms and conditions
of the 2023 Omnibus Plan. This summary is qualified in its entirety by reference to the 2023 Omnibus Plan attached as an exhibit to the
registration statement of which this Annual Report forms a part.

Administration

The
2023 Omnibus Plan is administered by our board of directors or our compensation committee, or any other committee or subcommittee or
one or more of our officers to whom authority has been delegated (collectively, the “Administrator”). The Administrator has
the authority to interpret the 2023 Omnibus Plan and award agreements entered into with respect to the 2023 Omnibus Plan; to make, change
and rescind rules and regulations relating to the 2023 Omnibus Plan; to make changes to, or reconcile any inconsistency in, the 2023
Omnibus Plan or any award agreement covering an award; and to take any other actions needed to administer the 2023 Omnibus Plan.

Eligibility

The
Administrator may designate any of the following as a participant under the 2023 Omnibus Plan: any officer or employee, or individuals
engaged to become an officer or employee, of our company or our affiliates; and consultants of our company or our affiliates, and our
directors, including our non-employee directors.

Types
of Awards

The
2023 Omnibus Plan permits the Administrator to grant stock options, stock appreciation rights (“SARs”), performance shares,
performance units, shares of common stock, restricted stock, restricted stock units (“RSUs”), cash incentive awards, dividend
equivalent units, or any other type of award permitted under the 202